Table 2.

Rates of determination of metastatic lesions by the imaging modalities based on the number of patients (number of patients: %)

Regions	FDG-PET/CT	CT	MRI
Pelvic lymph node	20/83, 24%	14/80, 17.5%	3/19, 15.7%
Abdominal lymph node	14/83, 16.8%	8/80, 10%	1/19, 5.2%
Mediastinal lymph node	6/83, 7.2%	2/80, 2.5%	1/2, 50%*
Lung	23/83, 27.7%	17/80, 21.2%	2/2, 100%*
Bone	20/83, 24%	3/80, 3.75%○	1/19, 5.2%○
Liver	7/83, 8.4%	4/80, 5%	0/19, 0%
Sub-renal	7/83, 8.4%	6/80, 7.5%	1/19, 5.2%

^*Only two patients have thoracic MRI images.

^○In thoracic, abdominal, and pelvic image regions.

PET/CT: positron emission tomography/computed tomography; TURBT: transurethral resection of bladder tumor; MRI: magnetic resonance imaging